Ater, J. L., Xia, C., Mazewski, C. M., Booth, T. N., Freyer, D. R., Packer, R. J., . . . Pollack, I. F. (2016). Non-randomized Comparison between Neurofibromatosis Type 1 (NF1) and Non-NF1 Children Who Received Carboplatin and Vincristine (CV) for Progressive Low Grade Glioma (LGG): A Report from the Children’s Oncology Group (COG). Cancer.
Chicago Style CitationAter, Joann L., Caihong Xia, Claire M. Mazewski, Timothy N. Booth, David R. Freyer, Roger J. Packer, Richard Sposto, Gilbert Vezina, i Ian F. Pollack. "Non-randomized Comparison between Neurofibromatosis Type 1 (NF1) and Non-NF1 Children Who Received Carboplatin and Vincristine (CV) for Progressive Low Grade Glioma (LGG): A Report From the Children’s Oncology Group (COG)." Cancer 2016.
Cita MLAAter, Joann L., et al. "Non-randomized Comparison between Neurofibromatosis Type 1 (NF1) and Non-NF1 Children Who Received Carboplatin and Vincristine (CV) for Progressive Low Grade Glioma (LGG): A Report From the Children’s Oncology Group (COG)." Cancer 2016.